These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2648704)

  • 21. Pharmacologic aspects of cyclosporine therapy: pharmacokinetics.
    Wood AJ; Lemaire M
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):27-32. PubMed ID: 3895666
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacodynamics of cyclosporine.
    Kahan BD; Yoshimura N; Pellis NR; Burstain T; Van Buren CT; Leinikki P; Schreiber RD; Roesel TR; Kerman RH
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):238-51. PubMed ID: 2947366
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of MHC product induction may contribute to the immunosuppressive action of ciclosporin.
    Halloran PF; Wadgymar A; Autenried P
    Prog Allergy; 1986; 38():258-68. PubMed ID: 2425369
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of treatment with anti-IL-2-receptor monoclonal antibody and CsA on peripheral nerve allograft rejection.
    Grochowicz PM; Romaniuk A; Diamantstein T; Olszewski WL
    Transplant Proc; 1987 Oct; 19(5):4302-3. PubMed ID: 3118540
    [No Abstract]   [Full Text] [Related]  

  • 25. The interleukin 2 receptor and its physiology. Implications for combatting autoimmune diseases and transplant rejections.
    Diamantstein T
    Behring Inst Mitt; 1987 Jun; (81):73-87. PubMed ID: 3115248
    [No Abstract]   [Full Text] [Related]  

  • 26. Unmasking immunosuppression.
    Lancet; 1991 Sep; 338(8770):789. PubMed ID: 1717800
    [No Abstract]   [Full Text] [Related]  

  • 27. Isomerase modification.
    Rakitzis ET
    Nature; 1989 Aug; 340(6232):351-2. PubMed ID: 2666859
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclosporine.
    Thomas SE; Gordon DS
    South Med J; 1986 Feb; 79(2):205-14. PubMed ID: 2418510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
    J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of chemical carcinogen-induced immunosuppression in mammary tumorigenesis in BALB-c mice.
    Medina D; Stockman G; Griswold D
    Cancer Res; 1974 Oct; 34(10):2663-8. PubMed ID: 4607071
    [No Abstract]   [Full Text] [Related]  

  • 32. [The inhibition of interleukin 2 (IL-2) receptor gene expression in kidney transplant recipients treated with ciclosporin: preliminary report].
    Yoshimura N; Oka T
    Nihon Geka Gakkai Zasshi; 1989 Jun; 90(6):956. PubMed ID: 2796968
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunosuppression: Cyclosporine.
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):149-208. PubMed ID: 3347950
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of various methods of chemical immunosuppression in islet cell transplantation.
    Bell PR; Wood RF; Peters M; Nash JR
    Transplant Proc; 1980 Jun; 12(2):291-3. PubMed ID: 6249004
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of cyclosporine binding by cyclophilin and calmodulin.
    Foxwell BM; Wong WC; Borel JF; Ryffel B
    Transplant Proc; 1989 Feb; 21(1 Pt 1):873-5. PubMed ID: 2650286
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunosuppressive therapy with cyclosporine for cardiac transplantation.
    Kahan BD
    Circulation; 1987 Jan; 75(1):40-56. PubMed ID: 3539397
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunosuppression by cyclosporine in vivo need not block effector T-cell function in mice.
    Auchincloss H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):860. PubMed ID: 2650285
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes.
    Colombani PM; Robb A; Hess AD
    Science; 1985 Apr; 228(4697):337-9. PubMed ID: 3885394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of action: ciclosporin- and prolactin-mediated control of immunity.
    Hiestand PC; Mekler P
    Prog Allergy; 1986; 38():239-46. PubMed ID: 3014546
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunopharmacology of cyclosporin A].
    Nikitin AV
    Antibiot Med Biotekhnol; 1986 Jan; 31(1):56-66. PubMed ID: 2418777
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.